Effective Ocular Delivery of Eplerenone Using Nanoengineered Lipid Carriers in Rabbit Model

Código QR

Effective Ocular Delivery of Eplerenone Using Nanoengineered Lipid Carriers in Rabbit Model

Eman Abdelhakeem, Mohamed El-nabarawi, Rehab Shamma Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Cairo University, Cairo, EgyptCorrespondence: Rehab ShammaDepartment of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Cairo University, Cairo, EgyptTel +20-0111...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Abdelhakeem E, El-nabarawi M, Shamma R
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2021
Materias:	eplerenone modified nanostructured lipid carriers chronic central serous chorioretinopathy surface modifiers Medicine (General) R5-920
Acceso en línea:	https://doaj.org/article/e3ad2d601cf34234bda78d66a2dff9ca
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Central Serous Chorioretinopathy: Pathogenesis and Management
por: Semeraro F, et al.
Publicado: (2019)

Antineoplastics Encapsulated in Nanostructured Lipid Carriers
por: Gustavo Henrique Rodrigues da Silva, et al.
Publicado: (2021)

Acute and subacute toxicity profiles of thymoquinone-loaded nanostructured lipid carrier in BALB/c mice
por: Ong YS, et al.
Publicado: (2016)

Recent developments in solid lipid nanoparticle and surface-modified solid lipid nanoparticle delivery systems for oral delivery of phyto-bioactive compounds in various chronic diseases
por: Ganesan P, et al.
Publicado: (2018)

Berberine-Loaded Nanostructured Lipid Carriers Enhance the Treatment of Ulcerative Colitis
por: Deng J, et al.
Publicado: (2020)

Pharmacokinetics and Biodistribution of Thymoquinone-loaded Nanostructured Lipid Carrier After Oral and Intravenous Administration into Rats
por: Zakarial Ansar FH, et al.
Publicado: (2020)

Selenium-coated nanostructured lipid carriers used for oral delivery of berberine to accomplish a synergic hypoglycemic effect
por: Yin J, et al.
Publicado: (2017)

Oral Spironolactone versus Conservative Treatment for Non-Resolving Central Serous Chorioretinopathy in Real-Life Practice
por: Sinawat S, et al.
Publicado: (2020)

Formulation design, characterization, and in vitro and in vivo evaluation of nanostructured lipid carriers containing a bile salt for oral delivery of gypenosides
por: Yang G, et al.
Publicado: (2019)

Lymph cancer chemotherapy: delivery of doxorubicin-gemcitabine prodrug and vincristine by nanostructured lipid carriers
por: Ni S, et al.
Publicado: (2017)

RIPL peptide-conjugated nanostructured lipid carriers for enhanced intracellular drug delivery to hepsin-expressing cancer cells
por: Lee SG, et al.
Publicado: (2018)

Clinical characteristics and long-term visual outcome of severe phenotypes of chronic central serous chorioretinopathy
por: Mohabati D, et al.
Publicado: (2018)

Quality by Design Approach for Preparation of Zolmitriptan/Chitosan Nanostructured Lipid Carrier Particles – Formulation and Pharmacodynamic Assessment
por: Awadeen RH, et al.
Publicado: (2020)

Enhanced antifungal activity of voriconazole-loaded nanostructured lipid carriers against Candida albicans with a dimorphic switching model
por: Tian B, et al.
Publicado: (2017)

Nanostructured lipid carriers based suppository for enhanced rectal absorption of ondansetron: In vitro and in vivo evaluations
por: Badriyah Shadid Alotaibi, et al.
Publicado: (2021)

Combined Technique and Its Clinical and Pathogenetic Evaluation in Treatment of Central Serous Chorioretinopathy Using Subthreshold Microimpulse Laser Irradiation with a Wavelength of 577 nm in Combination with Injections of Platelet Autoplasma
por: O. M. Stanishevskaya, et al.
Publicado: (2019)

Optimized Nanostructured Lipid Carriers Integrated into In Situ Nasal Gel for Enhancing Brain Delivery of Flibanserin
por: Fahmy UA, et al.
Publicado: (2020)

Improving intestinal absorption and oral bioavailability of curcumin via taurocholic acid-modified nanostructured lipid carriers
por: Tian C, et al.
Publicado: (2017)

Nanostructured lipid carriers co-delivering lapachone and doxorubicin for overcoming multidrug resistance in breast cancer therapy
por: Li X, et al.
Publicado: (2018)

Eplerenone nanocrystals engineered by controlled crystallization for enhanced oral bioavailability
por: Muhammad Ayub Khan, et al.
Publicado: (2021)

Development and evaluation of nanostructured lipid carrier-based hydrogel for topical delivery of 5-fluorouracil
por: Rajinikanth PS, et al.
Publicado: (2016)

Risk of Recurrence and Transition to Chronic Disease in Acute Central Serous Chorioretinopathy
por: Mohabati D, et al.
Publicado: (2020)

Changes of outer retinal microstructures after photodynamic therapy for chronic central serous chorioretinopathy
por: Shimizu K, et al.
Publicado: (2017)

Photodynamic therapy combined with antivascular endothelial growth factor treatment for recalcitrant chronic central serous chorioretinopathy
por: Asahi MG, et al.
Publicado: (2017)

Oleic acid-loaded nanostructured lipid carrier inhibits neutrophil activities in the presence of albumin and alleviates skin inflammation
por: Chen CY, et al.
Publicado: (2019)

Annatto Oil Loaded Nanostructured Lipid Carriers: A Potential New Treatment for Cutaneous Leishmaniasis
por: Marianna Araújo Ferreira, et al.
Publicado: (2021)

Methotrexate-Loaded Nanostructured Lipid Carrier Gel Alleviates Imiquimod-Induced Psoriasis by Moderating Inflammation: Formulation, Optimization, Characterization, In-Vitro and In-Vivo Studies
por: Agrawal YO, et al.
Publicado: (2020)

Dimeric c(RGD) peptide conjugated nanostructured lipid carriers for efficient delivery of Gambogic acid to breast cancer
por: Kebebe D, et al.
Publicado: (2019)

Development of ibuprofen-loaded nanostructured lipid carrier-based gels: characterization and investigation of in vitro and in vivo penetration through the skin
por: Sütő B, et al.
Publicado: (2016)

Subthreshold micropulse yellow laser treatment for nonresolving central serous chorioretinopathy
por: Abd Elhamid AH
Publicado: (2015)

Features of emotional and personality status of patients with central serous chorioretinopathy
por: A. A. Shchuko, et al.
Publicado: (2016)

Mucoadhesive, Thermoreversible Hydrogel, Containing Tetracaine-Loaded Nanostructured Lipid Carriers for Topical, Intranasal Needle-Free Anesthesia
por: Giovana Maria Fioramonti Calixto, et al.
Publicado: (2021)

Formulation And Evaluation Of Nanostructured Lipid Carriers (NLCs) Of 20(S)-Protopanaxadiol (PPD) By Box-Behnken Design
por: Kim MH, et al.
Publicado: (2019)

Enhanced transdermal delivery of lornoxicam by nanostructured lipid carrier gels modified with polyarginine peptide for treatment of carrageenan-induced rat paw edema
por: Gao S, et al.
Publicado: (2019)

Curcumin-loaded nanostructured lipid carriers prepared using Peceol™ and olive oil in photodynamic therapy: development and application in breast cancer cell line
por: Kamel AE, et al.
Publicado: (2019)

Lipid Nanoparticulate Drug Delivery Systems: Recent Advances in the Treatment of Skin Disorders
por: Stefan R. Stefanov, et al.
Publicado: (2021)

Microsecond yellow laser for subfoveal leaks in central serous chorioretinopathy
por: Ambiya V, et al.
Publicado: (2016)

Improved Bioavailability of Poorly Soluble Drugs through Gastrointestinal Muco-Adhesion of Lipid Nanoparticles
por: Sui Ling Janet Tan, et al.
Publicado: (2021)

Preparation and characterization of nimodipine-loaded nanostructured lipid systems for enhanced solubility and bioavailability
por: Teng Z, et al.
Publicado: (2018)

Lactoferrin- and RGD-comodified, temozolomide and vincristine-coloaded nanostructured lipid carriers for gliomatosis cerebri combination therapy
por: Zhang J, et al.
Publicado: (2018)